GUD.TO · Knight Therapeutics Inc.
Canada · RS rating 95 · As of 2026-10-14
| Price | 10.61 CAD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 89 / 79 / 90 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 59 / 50 |
| Industry group (rank) | Medical-Generic Drugs (45) |
| EPS growth Q/Q | -123.1% |
| Sales growth Q/Q | -2.9% |
| Distance from 52-week high | +2.0% |
| Market cap (USD) | $747.8M |